News Focus
News Focus
Followers 170
Posts 23227
Boards Moderated 1
Alias Born 12/09/2004

Re: brazen22 post# 827656

Tuesday, 05/26/2026 3:34:23 PM

Tuesday, May 26, 2026 3:34:23 PM

Post# of 828637
Dilution is selling shares to raise funds. Funds are what pays the bills in developmental companies until there is a revenue stream.

Selling shares is to be expected in a developmental biotech.

So yeah, NWBO is selling shares. It's what they have to do to stay alive while MHRA figures out what it is going to do with the MAA.

If you believe some of the posters here, NWBO can't partner because no company wants to partner. Or Linda is not willing to partner at this point because the deal is not worth the cost pre approval. Any partnership or licensing agreement will be much better for the company post approval.

I doubt that anyone anticipated that MHRA would take this long to make a decision on the MAA. So the company has to deal with the reality as it presents itself.

Success is the best revenge.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News